Biopharma companies everywhere aspire to make their data FAIR, for easy access, understanding, exchange, and reuse in AI-assisted analyses. To get there, data must be described with universal terms, like those found in public ontologies (e.g. BioAssay Ontology), ontology management systems (e.g. CENtree), and other structured databases. Genedata Screener registers new assays and annotates them with a combination of such sources.